SWP
ISEE

Stratos Wealth Partners’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Stratos Wealth Partners’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-70
Closed – – 2676
2018
Q3 		$0 Buy
+70
New +$174 ﹤0.01% 3070
2018
Q2 		– Sell
-70
Closed – – 2759
2018
Q1 		$0 Hold
70
– – ﹤0.01% 3257
2017
Q4 		$0 Buy
+70
New +$197 ﹤0.01% 2848

Other funds holding ISEE

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Stratos Wealth Partners's ISEE Position: Q4 2018 in Review

Stratos Wealth Partners sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q4 2018, closing a stake of 70 shares.

Stratos Wealth Partners first reported a position in ISEE in Q4 2017 and held it in 3 quarters. The position peaked at $0 in Q3 2018. 63 funds tracked by Wall St. Rank hold ISEE as of Q4 2018.

  • Stratos Wealth Partners reported no remaining IVERIC bio, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • Stratos Wealth Partners sold 70 IVERIC bio, Inc. Common Stock shares in Q4 2018.
  • Stratos Wealth Partners first reported a position in IVERIC bio, Inc. Common Stock in Q4 2017 and held it in 3 quarters.
  • Stratos Wealth Partners's IVERIC bio, Inc. Common Stock position peaked at $0 in Q3 2018.
  • 63 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q4 2018.

Based on Stratos Wealth Partners's 13F filing for Q4 2018, filed 8 Feb 2019.